Principal Financial Group’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$278M Sell
553,857
-70,864
-11% -$34M 0.14% 148
2026
Q1
$307M Sell
624,721
-16,889
-3% -$9.17M 0.16% 127
2025
Q4
$372M Buy
641,610
+70,109
+12% +$39.6M 0.19% 110
2025
Q3
$277M Sell
571,501
-626,401
-52% -$292M 0.14% 144
2025
Q2
$486M Sell
1,197,902
-31,076
-3% -$13M 0.26% 84
2025
Q1
$612M Buy
1,228,978
+12,063
+1% +$6.53M 0.34% 61
2024
Q4
$633M Sell
1,216,915
-30,923
-2% -$17M 0.35% 62
2024
Q3
$772M Buy
1,247,838
+225,568
+22% +$134M 0.42% 53
2024
Q2
$565M Buy
1,022,270
+247,110
+32% +$142M 0.34% 63
2024
Q1
$451M Buy
775,160
+166,547
+27% +$93.5M 0.26% 85
2023
Q4
$323M Sell
608,613
-10,563
-2% -$5.11M 0.21% 107
2023
Q3
$313M Buy
619,176
+2,067
+0.3% +$1.1M 0.23% 102
2023
Q2
$322M Sell
617,109
-11,128
-2% -$6M 0.22% 105
2023
Q1
$362M Buy
628,237
+32,303
+5% +$18.2M 0.26% 100
2022
Q4
$328M Sell
595,934
-17,409
-3% -$9.22M 0.25% 106
2022
Q3
$311M Sell
613,343
-21,413
-3% -$12M 0.25% 102
2022
Q2
$345M Sell
634,756
-15,245
-2% -$8.39M 0.26% 99
2022
Q1
$384M Sell
650,001
-12,509
-2% -$7.19M 0.24% 109
2021
Q4
$442M Sell
662,510
-32,518
-5% -$20.3M 0.26% 100
2021
Q3
$397M Buy
695,028
+15,220
+2% +$8.35M 0.26% 101
2021
Q2
$343M Buy
679,808
+6,576
+1% +$3.1M 0.22% 115
2021
Q1
$307M Sell
673,232
-32,842
-5% -$15.7M 0.22% 121
2020
Q4
$329M Sell
706,074
-74,646
-10% -$35M 0.24% 109
2020
Q3
$345M Sell
780,720
-49,078
-6% -$20.3M 0.29% 97
2020
Q2
$301M Buy
829,798
+30,433
+4% +$10.2M 0.26% 101
2020
Q1
$227M Sell
799,365
-19,641
-2% -$6.19M 0.25% 108
2019
Q4
$266M Buy
819,006
+48,648
+6% +$14.8M 0.22% 119
2019
Q3
$224M Buy
770,358
+51,008
+7% +$14.6M 0.2% 130
2019
Q2
$211M Buy
719,350
+51,518
+8% +$14.2M 0.19% 132
2019
Q1
$183M Sell
667,832
-17,579
-3% -$4.37M 0.17% 145
2018
Q4
$153M Sell
685,411
-9,652
-1% -$2.26M 0.16% 152
2018
Q3
$170M Buy
695,063
+6,250
+0.9% +$1.44M 0.15% 158
2018
Q2
$143M Sell
688,813
-6,499
-0.9% -$1.38M 0.13% 187
2018
Q1
$144M Sell
695,312
-24,207
-3% -$5.08M 0.14% 183
2017
Q4
$137M Sell
719,519
-87,326
-11% -$16.7M 0.13% 217
2017
Q3
$153M Buy
806,845
+229
+0% +$41.5K 0.15% 173
2017
Q2
$141M Buy
806,616
+245,662
+44% +$41.3M 0.14% 187
2017
Q1
$86.2M Sell
560,954
-8,202
-1% -$1.25M 0.1% 209
2016
Q4
$80.3M Sell
569,156
-8,907
-2% -$1.31M 0.1% 210
2016
Q3
$91.9M Buy
578,063
+11,392
+2% +$1.76M 0.12% 177
2016
Q2
$83.7M Buy
566,671
+29,782
+6% +$4.4M 0.12% 189
2016
Q1
$76M Buy
536,889
+2,294
+0.4% +$307K 0.11% 207
2015
Q4
$75.8M Buy
534,595
+12,627
+2% +$1.68M 0.11% 208
2015
Q3
$63.8M Buy
521,968
+5,698
+1% +$742K 0.1% 227
2015
Q2
$67M Buy
516,270
+7,978
+2% +$1.04M 0.1% 237
2015
Q1
$68.3M Buy
508,292
+12,533
+3% +$1.62M 0.1% 239
2014
Q4
$62.1M Buy
495,759
+19,097
+4% +$2.32M 0.1% 248
2014
Q3
$58M Sell
476,662
-369,196
-44% -$44.9M 0.1% 248
2014
Q2
$99.8M Buy
845,858
+356,391
+73% +$41.9M 0.17% 163
2014
Q1
$58.9M Buy
489,467
+90,025
+23% +$10.7M 0.11% 246
2013
Q4
$44.5M Buy
399,442
+1,729
+0.4% +$172K 0.08% 279
2013
Q3
$36.6M Sell
397,713
-10,629
-3% -$961K 0.08% 304
2013
Q2
$34.6M Buy
+408,342
New +$34M 0.08% 301

Other funds holding TMO

Principal Financial Group's TMO Position: Q2 2026 in Review

Principal Financial Group reduced its Thermo Fisher Scientific (TMO) stake by 11% in Q2 2026, selling an estimated $34M and leaving 553,857 shares worth $278M. The position accounts for 0.14% of the portfolio, ranked #148.

Principal Financial Group first reported a position in TMO in Q2 2013 and has held it in 53 quarters since. The position peaked at $772M in Q3 2024. 2,602 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Principal Financial Group held 553,857 shares of Thermo Fisher Scientific worth $278M as of Q2 2026.
  • Principal Financial Group sold 70,864 Thermo Fisher Scientific shares in Q2 2026, an estimated $34M.
  • Thermo Fisher Scientific made up 0.14% of Principal Financial Group's portfolio in Q2 2026, its #148 holding.
  • Principal Financial Group first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 53 quarters since.
  • Principal Financial Group's Thermo Fisher Scientific position peaked at $772M in Q3 2024.
  • 2,602 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Principal Financial Group's 13F filing for Q2 2026, filed 4 Aug 2026.